Dr. Ku discusses considerations in the treatment of esophageal cancer, current treatments, and the emerging role of immunotherapy.
Geoffrey Y. Ku, MD
Advertisement
Articles by Geoffrey Y. Ku, MD
Ahead of the 2017 ASCO Gastrointestinal Cancer Symposium in San Francisco, we spoke with Dr. Geoffrey Ku on the advances in systemic therapy for esophageal and gastric cancer.
Advertisement
Latest Updated Articles
Immunotherapy Treatments Only Just Emerging in Esophageal, Gastric CancersPublished: January 18th 2017 | Updated:
Current Treatment of Esophageal Cancer and Promising Clinical Trials UnderwayPublished: March 13th 2019 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Pembrolizumab Combo Does Not Significantly Improve OS in Unresectable HCC
2
H.R. 2541: Examining Its Legislative Impact on Radiopharmaceutical Practice
3
177Lu-PSMA-I&T/223Ra Display Safety and Feasibility in Metastatic CRPC
4
FDA Grants Iopofosine I 131 Rare Pediatric Drug Designation in R/R Glioma
5
